Intra and Inter- Observer Reproducibility of Ankle Dorsiflexion Measure With a New Tool
NCT ID: NCT04792359
Last Updated: 2021-04-26
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
30 participants
INTERVENTIONAL
2021-04-22
2021-09-10
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
This equine whose prevalence in the general population is greater than 50% according to Kowalski, appears to be a risk factor in many pathologies of the foot and ankle.
Currently, in clinical practice, the measurement of passive dorsiflexion of the ankle is empirically measured by the Silfverskiold test. However, the definition of a retraction varies according to the authors, in particular because of the absence of normalization of the force applied on the forefoot, or of the absence of uniformization of the angulation applied. This research is based on the hypothesis that a new measurement tool would be more efficient and more reproducible for measuring dorsiflexion of the ankle.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Cartography and Quantitative Characterization of Achilles Tendon Fibrocartilage by TE = 0ms Imaging at 3T MRI
NCT03287596
Development of Achilles Tendon Elongation and Its Effect on Physical Function the First Year After Rupture
NCT03525314
Longitudinal Changes in Achilles Tendon and Medial Gastrocnemius Muscle Architecture During a 156-km Ultradistance Trail Running Event
NCT06297317
Early Controlled Loading on Conservative Treated Achilles Tendon Ruptures
NCT02805751
Responsiveness of Quantitative Musculoskeletal Ultrasound Measures on the Healing of Achilles Tendon
NCT04651985
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
BASIC_SCIENCE
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Equinometer
Measurement with Equinometer
Equinometer
Measurement of dorsiflexion of the ankle will be reproduced three times on each ankle in two positions, with a force applied
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Equinometer
Measurement of dorsiflexion of the ankle will be reproduced three times on each ankle in two positions, with a force applied
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Student at the IFMK school (Paris)
* Participant without any trauma at the Achilles' tendon
* Participant who has been given appropriate information about the study objectives and who has given his/her express written and informed consent prior to conduct any study-related procedures.
Exclusion Criteria
* Participant whose physical and / or psychological health is severely impaired, which according to the investigator may affect the participant's compliance with the study
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
GCS Ramsay Santé pour l'Enseignement et la Recherche
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Julien BELDAME, MD
Role: PRINCIPAL_INVESTIGATOR
RGDS-Clinique Blomet
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Clinique Blomet
Paris, , France
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Julien Beldame, MD
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2020-A03518-31
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.